Aideen McCabe investigates earlier ovarian cancer detection through improved laboratory cell models and RNA-based biomarkers. Her research aims to identify suitable cell lines, discover potential diagnostic indicators and inform future treatments. Guided by patient partners, the project seeks to translate laboratory discoveries into clinical advances that improve patient outcomes.